Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-20
2005-12-20
Tsang, Cecilia J. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S315000, C514S318000, C514S319000, C514S322000, C514S324000, C514S327000, C546S024000, C546S192000, C546S193000, C546S196000, C546S202000, C546S205000, C546S210000, C546S212000, C546S213000, C546S214000, C546S216000, C546S242000, C546S243000
Reexamination Certificate
active
06977260
ABSTRACT:
The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I;wherein X, Y, Z, D and R3are as defined in the specification.
REFERENCES:
patent: 4994274 (1991-02-01), Chan et al.
patent: 5028624 (1991-07-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
patent: 5446041 (1995-08-01), Chan et al.
patent: 2004/0142969 (2004-07-01), Elworthy
patent: WO2004/063158 (1929-04-01), None
patent: WO2004/085430 (2004-07-01), None
Bito, L.Z.,Biological Protection with Prostaglandins, Cohen, M.M., ed., Boca Raton, Fla, CRC Press Inc., 1985, pp. 231-252.
Bito, L.Z.,Applied Pharmacology in the Medical Treatment of Glaucomas, Drance, S.M. and Neufeld, A.H. eds, New York, Grune & Stratton, 1984, pp. 477-505.
Nilsson et al, Invest.Ophthalmol. Vis. Sci.(suppl), 284 (1987).
Bito, L.Z.,Arch. Ophthalmol.105, 1036 (1987).
Siebold et al,Prodrug5 3 1989.
Huang et al, Synth. Commun., “Preparation of Optically Pure ω-Hydroxymethyl Lactams”, 1989, 19, 3485-3496.
Dinh Danny T.
Old David W.
Allergan Inc.
Baran Robert J.
Covington Raymond
Johnson Brent A.
Tsang Cecilia J.
LandOfFree
Piperidinyl prostaglandin E analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidinyl prostaglandin E analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidinyl prostaglandin E analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3500177